. 2017 Dec 30;9(6):527–534. doi: 10.5114/jcb.2017.72605

Table 3.

Univariate analysis of survival of 182 patients with stage III non-small cell lung carcinoma

Factors		n	1-year survival rate (%)	3-year survival rate (%)	5-year survival rate (%)	Χ²	p
Hemoglobin before treatment (g/l)	< 120	80	82.50	10.77	6.28	13.022	0.000
Hemoglobin before treatment (g/l)	≥ 120	102	84.08	37.02	12.94	13.022	0.000
Smoking index (pack [20 cigarettes])/year	< 80	83	95.20	37.15	18.73	4.016	0.048
Smoking index (pack [20 cigarettes])/year	≥ 80	99	82.37	24.61	8.31	4.016	0.048
Diameter of tumors (cm)	< 3.0	62	93.54	42.64	17.50	27.449	0.000
	3.0-5.0	37	83.78	23.45	4.47
	5.1-7.0	83	72.93	11.19	0
T stages	T1+T2	27	96.30	38.23	19.66	4.366	0.037
T stages	T3+T4	155	81.10	23.53	7.98	4.366	0.037
D₁₀₀ after treatment (Gy)	≤ 80	16	43.75	6.25	0.00	25.052	0.000
	80-110	139	86.90	21.65	7.29
	> 110	27	88.89	46.60	20.7

D₁₀₀ – dose covering 100% of the target volume